6 compared with 12 weeks treatment in the von Rosen splint is sufficient for Barlow and Ortolani positive hips: a

Adam Sand1, Carl Johan Tiderius2, Henrik Düppe2

  • 1Department of Orthopaedics, Lund University, Skåne University Hospital, Sweden. adam.sand@med.lu.se.

Acta Orthopaedica
|June 22, 2023
PubMed

Insights

Treating newborns with hip dysplasia using the von Rosen splint for 6 weeks is as effective as 12 weeks for acetabular development. However, closer follow-up is needed for the shorter treatment duration to monitor for complications like hip dislocation.

Area of Science:

  • Pediatric Orthopedics
  • Developmental Dysplasia of the Hip

Background:

  • The von Rosen abduction splint has been used for 12 weeks to treat newborns with hip dysplasia.
  • Treatment duration was halved to 6 weeks in 2012.
  • The study compares outcomes of 6-week versus 12-week splinting.

Purpose of the Study:

  • To investigate if acetabular development at 12 months differs between infants treated with the von Rosen splint for 6 versus 12 weeks.
  • To compare complication rates between the two treatment durations.

Main Methods:

  • Retrospective study of 99 patients (6-week group) and 138 patients (12-week group).
  • Acetabular index (AI) measured at 12 months via pelvic radiographs.
  • Complications and additional treatments reviewed up to age 12 months.
  • Non-inferiority testing used for comparison.

Main Results:

  • Mean AI at 12 months was 25° in both the 6-week and 12-week groups.
  • Non-inferiority of the 6-week program was demonstrated (mean difference -0.2°, 95% CI -1.1 to 0.7).
  • 8 patients in the 6-week group required additional treatment, including one hip dislocation between 6 weeks and 3 months.
  • No additional treatments or complications were observed in the 12-week group.

Conclusions:

  • Acetabular development is comparable at 12 months of age regardless of 6 or 12 weeks of von Rosen splint treatment.
  • The occurrence of hip dislocation in the 6-week group highlights the need for close follow-up around 3 months of age.
Abstract